Japan Laboratory Automation Market

Japan Laboratory Automation Market Insights Forecasts to 2035

• The Japan Laboratory Automation Market Size Was Estimated at USD 398.6 Million in 2024
• The Market Size is Expected to Grow at a CAGR of Around 5.86% from 2025–2035
• The Japan Laboratory Automation Market Size is Expected to Reach USD 745.5 Million by 2035

According to a research report published by Decision Advisor & Consulting, the Japan Laboratory Automation Market is anticipated to reach USD 745.5 Million by 2035, growing at a CAGR of 5.86% from 2025–2035. The Japanese laboratory automation market is driven by increasing demand for high-throughput testing, a rising shortage of skilled laboratory technicians, and the rapid adoption of fully automated analyzers and robotics in diagnostic workflows. Integration of digital technologies such as AI-supported processing, smart laboratory information systems, and automated sample handling continues to accelerate market expansion across hospitals and diagnostic networks in Japan.

Market Overview

The Japan laboratory automation market refers to automated technologies, instruments, software, and workflow systems used to streamline laboratory processes such as sample handling, testing, analysis, data management, and quality control. Laboratory automation improves efficiency, accuracy, and testing throughput while reducing manual errors and operational costs. Market trends reflect a fast shift toward robotics-driven sample processing, integration of AI-enabled analytics platforms, and adoption of advanced instruments supporting full or semi-automated processes for clinical diagnostics and research. Key market characteristics include Japan’s high healthcare digitization rate, investment in precision medicine laboratories, and strong demand for automation due to an aging workforce and rising chronic disease burden. Important market drivers include growing test volumes in clinical chemistry and immunology, rapid expansion of molecular laboratories, and the need for reproducible and standardized laboratory workflows across healthcare facilities.

 Japan’s Digital Health Transformation Strategy, national funding for AI-powered diagnostic labs, and modernization programs supporting smart hospital infrastructures further stimulate the adoption of automation technologies across the clinical testing ecosystem.

Report Coverage

This research report categorizes the market for the Japan laboratory automation market based on various segments and regions, and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Japan laboratory automation market. Recent market developments and competitive strategies, such as expansion, product launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Japan laboratory automation market.

Driving Factor

The Japanese laboratory automation market is driven by the rising demand for high-volume diagnostic testing, the need to overcome staffing shortages in clinical laboratories, and the rapid adoption of automated analyzers and robotics that improve efficiency and accuracy. Growth is further supported by increased integration of AI-based workflow systems, expansion of molecular testing, and government initiatives promoting digital transformation of healthcare infrastructure and laboratory modernization.

Restraining Factor

The Japanese laboratory automation market faces restraints such as high initial investment costs for advanced automation systems, integration challenges within legacy laboratory infrastructures, and limited adoption among smaller facilities. Regulatory complexity and slow procurement cycles may further hinder rapid system deployment.

Market Segmentation

The Japan Laboratory Automation Market share is categorized by test type, technology, and sample type.

• The laboratory testing accounted for the largest revenue share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The Japanese laboratory automation market is segmented by test type into laboratory testing, point-of-care testing (POCT), imaging diagnostics, molecular diagnostics, and others. Among these, the laboratory testing segment accounted for the largest revenue share in 2024 and is expected to grow at a significant CAGR during the forecast period. The segment growth is driven by the increasing adoption of automated analyzers for hematology, clinical chemistry, immunology, and microbiology tests, which streamline laboratory workflows, improve test accuracy, and reduce turnaround times. Hospitals and diagnostic laboratories are increasingly implementing fully automated laboratory solutions to handle the growing volume of patient samples and to meet rising demand for rapid diagnostics, preventive screening, and large-scale clinical trials, making laboratory testing the most dominant segment in Japan’s laboratory automation market.

• The PCR-Based segment accounted for the largest revenue share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The Japanese laboratory automation market is segmented by technology into immunoassay-based, PCR-based, NEXT gen sequencing, spectroscopy-based, chromatography-based, microfluidics, and others. Among these, the PCR-Based segment accounted for the largest revenue share in 2024 and is expected to grow at a significant CAGR during the forecast period. The segment growth is driven by rising need for accurate pathogen detection, high-throughput genetic testing, and advanced molecular diagnostics, which are efficiently performed using automated PCR systems. The increased use of PCR automation in hospitals, diagnostic laboratories, and research institutes is driven by rapid detection of infectious diseases, personalized medicine, and monitoring of genetic disorders, making it a critical technology for the Japanese market.

• The blood segment accounted for the largest revenue share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The Japanese laboratory automation market is segmented by sample type into Blood, Urine, Saliva, Sweat, Hair, and Others. Among these, the blood segment accounted for the largest revenue share in 2024 and is expected to grow at a significant CAGR during the forecast period. The segment growth is driven by automation in blood-based testing enables faster and more accurate processing of routine tests, including hematology, clinical chemistry, and immunoassays, while minimizing human errors. The segment’s dominance is further supported by the high volume of blood tests performed daily in hospitals, diagnostic labs, and research facilities, along with the growing demand for high-throughput screening, chronic disease monitoring, and preventive healthcare programs, establishing blood-based testing as the key contributor to revenue growth in Japan’s laboratory automation market.

Competitive Analysis

The report offers the appropriate analysis of the key organizations/companies involved within the Japan laboratory automation market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Sysmex Corporation
• Hitachi High-Tech Corporation
• Fujifilm Holdings Corporation
• Roche Diagnostics Japan
• Siemens Healthineers Japan
• Beckman Coulter Japan
• Abbott Japan
• Shimadzu Corporation
• H.U. Group Holdings
• Thermo Fisher Scientific Japan
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities
• Consulting and Research Firms
• Venture Capitalists
• Value-Added Resellers (VARs)

Recent Developments

• In February 2025, Sysmex Corporation launched its next-generation fully automated laboratory workflow platform featuring advanced robotics, real-time data integration, and AI-supported process optimization for high-throughput clinical laboratories across Japan.

Market Segment

This study forecasts revenue at the Japan, regional, and country levels from 2020 to 2035. Decision Advisor has segmented the Japan Laboratory Automation Market based on the segments below:

Japan Laboratory Automation Market, By Test Type

• Laboratory Testing
• Point-of-Care Testing (POCT)
• Imaging Diagnostics
• Molecular Diagnostics
• Others

Japan Laboratory Automation Market, By Technology

• Immunoassay-Based
• PCR-Based
• Next Gen Sequencing
• Spectroscopy-Based
• Chromatography-Based
• Microfluidics
• Others

Japan Laboratory Automation Market, By Sample Type

• Blood
• Urine
• Saliva
• Sweat
• Hair
• Others

Frequently Asked Questions (FAQs)

Q: What is the Japan Laboratory Automation Market size?

A: The Japan Laboratory Automation Market is expected to grow from USD 398.6 million in 2024 to USD 745.5 million by 2035, at a CAGR of 5.86%.

Q: What factors restrain the Japan Laboratory Automation Market?

A: Key restraints include high acquisition costs, integration challenges, and slow adoption among smaller healthcare facilities.

Q: How is the market segmented by component?

A: The market is segmented into instruments, software, and services.

Q: Who are the key players in the Japan Laboratory Automation Market?

A: Major players include Sysmex, Hitachi High-Tech, Roche Diagnostics, Siemens Healthineers, Fujifilm, and others.